id | C00003416 |
---|---|
Name | Coleonol / Forskolin |
CAS RN | 66575-29-9 |
Standard InChI | InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3 |
Phytochemical cluster | No. 41 |
---|---|
KCF-S cluster | No. 531 |
By standard InChI | CHEMBL52606 |
---|---|
By standard InChI Main Layer | CHEMBL52606 CHEMBL147623 CHEMBL1358402 CHEMBL1398667 CHEMBL1414148 CHEMBL1473060 CHEMBL1904897 CHEMBL1990053 |
By LinkDB | C09076 |
---|
By CAS RN |
---|
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Coleus forskohlii | 41228 | Lamiaceae | asterids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1398667 CHEMBL1473060 |
CHEMBL1614110
(1)
CHEMBL1741321
(2)
|
1 / 0 |
P13569 | Cystic fibrosis transmembrane conductance regulator | chloride | CHEMBL52606 |
CHEMBL661349
(1)
|
2 / 3 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL1414148 |
CHEMBL1613842
(1)
|
4 / 2 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL1358402 |
CHEMBL2114744
(1)
|
0 / 0 |
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | CHEMBL52606 |
CHEMBL901742
(1)
|
0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL1398667 CHEMBL1473060 |
CHEMBL1614281
(2)
CHEMBL1614361
(2)
|
3 / 2 |
P11166 | Solute carrier family 2, facilitated glucose transporter member 1 | Glucose uniporter | CHEMBL52606 |
CHEMBL684234
(1)
|
4 / 2 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL52606 |
CHEMBL2076213
(1)
CHEMBL2076214
(1)
CHEMBL2076218 (1) |
1 / 0 |
Q08828 | Adenylate cyclase type 1 | Enzyme | CHEMBL52606 |
CHEMBL646259
(1)
CHEMBL645667
(1)
CHEMBL645668 (1) CHEMBL645672 (1) CHEMBL645673 (1) |
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1398667 CHEMBL1473060 |
CHEMBL1741325
(2)
|
0 / 1 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL1358402 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
Q9HBX9 | Relaxin receptor 1 | Relaxin receptor | CHEMBL52606 |
CHEMBL1738202
(1)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL1398667 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL52606 CHEMBL1358402 |
CHEMBL1613941
(1)
CHEMBL2114780
(1)
|
0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL52606 |
CHEMBL2114931
(1)
|
0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL52606 |
CHEMBL1614410
(1)
|
1 / 3 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL52606 |
CHEMBL1794401
(1)
|
0 / 0 |
P51843 | Nuclear receptor subfamily 0 group B member 1 | Nuclear hormone receptor subfamily 0 group B member 1 | CHEMBL52606 |
CHEMBL2354292
(1)
|
2 / 2 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL52606 |
CHEMBL1794293
(1)
|
5 / 3 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL1358402 CHEMBL1398667 CHEMBL1414148 CHEMBL1473060 |
CHEMBL1614521
(2)
CHEMBL1613808
(3)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1398667 CHEMBL1473060 |
CHEMBL1741322
(2)
|
0 / 0 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | CHEMBL1358402 |
CHEMBL1614171
(1)
|
5 / 2 |
Q8WXD0 | Relaxin receptor 2 | Relaxin receptor | CHEMBL52606 |
CHEMBL1738172
(1)
|
1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL1358402 |
CHEMBL1737868
(1)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL52606 |
CHEMBL1794364
(1)
CHEMBL1794542
(1)
|
1 / 1 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL1398667 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
Q8WUI4 | Histone deacetylase 7 | Hydrolase | CHEMBL52606 |
CHEMBL1267832
(1)
CHEMBL1267833
(1)
CHEMBL1267834 (1) CHEMBL1267835 (1) |
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1398667 CHEMBL1473060 |
CHEMBL1613777
(1)
CHEMBL1741323
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1398667 CHEMBL1414148 CHEMBL1473060 |
CHEMBL1614108
(3)
CHEMBL1613886
(3)
CHEMBL1741324 (2) |
0 / 1 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | CHEMBL1358402 |
CHEMBL1614052
(1)
|
1 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL52606 |
CHEMBL2114890
(1)
|
0 / 0 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | CHEMBL52606 |
CHEMBL690192
(1)
CHEMBL695976
(1)
|
1 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | CHEMBL52606 |
CHEMBL2114849
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL1904897 |
CHEMBL1794536
(1)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL1358402 |
CHEMBL1738442
(1)
|
0 / 0 |
O60266 | Adenylate cyclase type 3 | Enzyme | CHEMBL52606 |
CHEMBL646259
(1)
|
0 / 0 |
O43306 | Adenylate cyclase type 6 | Enzyme | CHEMBL52606 |
CHEMBL646259
(1)
|
0 / 0 |
Q08462 | Adenylate cyclase type 2 | Enzyme | CHEMBL52606 |
CHEMBL646259
(1)
|
0 / 0 |
O60503 | Adenylate cyclase type 9 | Enzyme | CHEMBL52606 |
CHEMBL646259
(1)
|
0 / 0 |
P51828 | Adenylate cyclase type 7 | Enzyme | CHEMBL52606 |
CHEMBL646259
(1)
|
0 / 0 |
P40145 | Adenylate cyclase type 8 | Enzyme | CHEMBL52606 |
CHEMBL646259
(1)
|
0 / 0 |
O95622 | Adenylate cyclase type 5 | Enzyme | CHEMBL52606 |
CHEMBL646259
(1)
|
1 / 0 |
Q8NFM4 | Adenylate cyclase type 4 | Enzyme | CHEMBL52606 |
CHEMBL646259
(1)
|
0 / 0 |
Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | CHEMBL52606 |
CHEMBL806152
(1)
CHEMBL806154
(1)
|
0 / 0 |
Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | CHEMBL52606 |
CHEMBL806152
(1)
CHEMBL806154
(1)
|
2 / 2 |
P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | CHEMBL52606 |
CHEMBL806152
(1)
CHEMBL806154
(1)
|
3 / 2 |
OMIM | preferred title | UniProt |
---|---|---|
#300018 | 46,xy sex reversal 2; srxy2 |
P51843
|
#300200 | Adrenal hypoplasia, congenital; ahc |
P51843
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#210900 | Bloom syndrome; blm |
P54132
|
%606641 | Body mass index; bmi |
P37231
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#219050 | Cryptorchidism, unilateral or bilateral |
Q8WXD0
|
#219700 | Cystic fibrosis; cf |
P13569
|
#607208 | Dravet syndrome |
P35498
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#606703 | Dyskinesia, familial, with facial myokymia; fdfm |
O95622
|
#601042 | Dystonia 9; dyt9 |
P11166
|
#614847 | Epilepsy, idiopathic generalized, susceptibility to, 12; eig12 |
P11166
|
#613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
#615363 | Estrogen resistance; estrr |
P03372
|
#604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#606777 | Glut1 deficiency syndrome 1; glut1ds1 |
P11166
|
#612126 | Glut1 deficiency syndrome 2; glut1ds2 |
P11166
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#601665 | Obesity |
P37231
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#277180 | Vas deferens, congenital bilateral aplasia of; cbavd |
P13569
|
KEGG | disease name | UniProt |
---|---|---|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00831 | Primary dystonia |
P11166
(related)
|
H00836 | GLUT1 deficiency syndrome (GLUT1DS) |
P11166
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00218 | Cystic fibrosis (CF) |
P13569
(related)
|
H00933 | Hereditary pancreatitis |
P13569
(related)
|
H01033 | Congenital bilateral absence of vas deferens |
P13569
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
H00783 | Febrile seizures |
P35498
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00552 | Glycerol kinase deficiency (GKD) |
P51843
(related)
|
H00607 | 46,XY disorders of sex development (Disorders of gonadal development) |
P51843
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
Q01453
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00609 | 46,XY disorders of sex development (Other) |
Q8WXD0
(related)
|
H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|